NASDAQ:GNCA

Genocea Biosciences News Headlines

$2.31
-0.03 (-1.28 %)
(As of 06/18/2021 03:59 PM ET)
Add
Compare
Today's Range
$2.25
$2.33
50-Day Range
$2.06
$2.82
52-Week Range
$1.74
$5.75
Volume1,404 shs
Average Volume461,475 shs
Market Capitalization$125.74 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65

Genocea Biosciences (NASDAQ GNCA) News Headlines Today

SourceHeadline
Its Probably Less Likely That Genocea Biosciences, Inc.s (NASDAQ:GNCA) CEO Will See A Huge Pay Rise This YearIt's Probably Less Likely That Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Will See A Huge Pay Rise This Year
finance.yahoo.com - June 17 at 12:45 PM
Genocea Biosciences, Inc. (NASDAQ:GNCA) Expected to Announce Earnings of -$0.18 Per ShareGenocea Biosciences, Inc. (NASDAQ:GNCA) Expected to Announce Earnings of -$0.18 Per Share
americanbankingnews.com - June 10 at 5:10 PM
Genocea Presents Promising Long-term Results from GEN-009 Neoantigen Vaccine Phase 1 Trial at ASCO 2021Genocea Presents Promising Long-term Results from GEN-009 Neoantigen Vaccine Phase 1 Trial at ASCO 2021
finance.yahoo.com - June 4 at 11:09 AM
Do Institutions Own Genocea Biosciences, Inc. (NASDAQ:GNCA) Shares?Do Institutions Own Genocea Biosciences, Inc. (NASDAQ:GNCA) Shares?
finance.yahoo.com - May 30 at 1:19 PM
Genocea Biosciences (GNCA) Reports Q1 Loss, Misses Revenue EstimatesGenocea Biosciences (GNCA) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - April 29 at 1:05 PM
Genocea Provides First Quarter 2021 Corporate UpdateGenocea Provides First Quarter 2021 Corporate Update
finance.yahoo.com - April 29 at 8:04 AM
Genocea To Host First Quarter 2021 Corporate Update Conference Call & WebcastGenocea To Host First Quarter 2021 Corporate Update Conference Call & Webcast
finance.yahoo.com - April 22 at 6:14 PM
Genocea to Present at the 20th Annual Needham Virtual Healthcare ConferenceGenocea to Present at the 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 6 at 7:46 PM
Genocea to Present at the H.C. Wainwright Global Life Sciences ConferenceGenocea to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 6:56 PM
Genocea Provides Fourth Quarter 2020 Corporate UpdateGenocea Provides Fourth Quarter 2020 Corporate Update
finance.yahoo.com - February 11 at 12:25 PM
Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & WebcastGenocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast
finance.yahoo.com - February 4 at 4:18 PM
Genocea Announces Publication in Cancer Discovery Highlighting the Advantages of Neoantigen Identification with the ATLAS™ PlatformGenocea Announces Publication in Cancer Discovery Highlighting the Advantages of Neoantigen Identification with the ATLAS™ Platform
finance.yahoo.com - January 28 at 8:38 AM
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor ConferenceGenocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference
finance.yahoo.com - January 19 at 8:42 PM
Genocea to Participate in the B. Riley Securities Virtual Oncology Investor ConferenceGenocea to Participate in the B. Riley Securities' Virtual Oncology Investor Conference
feeds.benzinga.com - January 19 at 7:51 PM
Genocea to Present at the H.C. Wainwright Virtual BioConnect ConferenceGenocea to Present at the H.C. Wainwright Virtual BioConnect Conference
feeds.benzinga.com - January 4 at 4:29 PM
Is the Options Market Predicting a Spike in Genocea (GNCA) Stock?Is the Options Market Predicting a Spike in Genocea (GNCA) Stock?
finance.yahoo.com - December 28 at 12:38 PM
GNCA Jan 2021 2.500 putGNCA Jan 2021 2.500 put
uk.finance.yahoo.com - December 26 at 11:47 PM
What Is The Ownership Structure Like For Genocea Biosciences, Inc. (NASDAQ:GNCA)?What Is The Ownership Structure Like For Genocea Biosciences, Inc. (NASDAQ:GNCA)?
finance.yahoo.com - December 21 at 7:41 AM
Is GNCA A Good Stock To Buy Now?Is GNCA A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 9:05 PM
Genocea to Present at the Stifel 2020 Virtual Healthcare ConferenceGenocea to Present at the Stifel 2020 Virtual Healthcare Conference
finance.yahoo.com - November 12 at 8:39 AM
Genocea Presents Positive GEN-009 Clinical Results, Update on GEN-011 Program and New InhibigenTM Mechanism of Action Data at Virtual SITC 2020Genocea Presents Positive GEN-009 Clinical Results, Update on GEN-011 Program and New InhibigenTM Mechanism of Action Data at Virtual SITC 2020
finance.yahoo.com - November 9 at 9:01 AM
Genocea to Host Investor Call Highlighting New GEN-009 Clinical and Immunogenicity Data to be Presented at Virtual SITC 2020Genocea to Host Investor Call Highlighting New GEN-009 Clinical and Immunogenicity Data to be Presented at Virtual SITC 2020
markets.businessinsider.com - November 5 at 7:07 PM
Genocea Biosciences, Incs (GNCA) CEO Chip Clark on Q3 2020 Results - Earnings Call TranscriptGenocea Biosciences, Inc's (GNCA) CEO Chip Clark on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - October 29 at 2:38 PM
Genocea Biosciences, Inc. to Host Earnings CallGenocea Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - October 29 at 9:38 AM
Genocea Provides Third Quarter 2020 Corporate UpdateGenocea Provides Third Quarter 2020 Corporate Update
finance.yahoo.com - October 29 at 9:38 AM
Genocea to Host Third Quarter 2020 Corporate Update Conference Call & WebcastGenocea to Host Third Quarter 2020 Corporate Update Conference Call & Webcast
feeds.benzinga.com - October 22 at 5:28 PM
Does Genocea Biosciences' (NASDAQ:GNCA) CEO Salary Compare Well With Industry Peers?Does Genocea Biosciences' (NASDAQ:GNCA) CEO Salary Compare Well With Industry Peers?
finance.yahoo.com - October 22 at 12:45 PM
Is Genocea Biosciences (GNCA) Stock Outpacing Its Medical Peers This Year?Is Genocea Biosciences (GNCA) Stock Outpacing Its Medical Peers This Year?
nasdaq.com - October 15 at 2:28 PM
Genocea Announces Upcoming Data Presentations at Virtual SITC 2020Genocea Announces Upcoming Data Presentations at Virtual SITC 2020
markets.businessinsider.com - October 14 at 6:18 PM
Genocea to Initiate a Phase I/II Oncology Study on GEN-011Genocea to Initiate a Phase I/II Oncology Study on GEN-011
finance.yahoo.com - September 23 at 12:56 PM
Genocea Up 5% On FDA Nod For Cancer Therapy Application; Street Sees 353% UpsideGenocea Up 5% On FDA Nod For Cancer Therapy Application; Street Sees 353% Upside
finance.yahoo.com - September 22 at 8:19 PM
Genocea on go with early-stage study of cancer candidate GEN-011Genocea on go with early-stage study of cancer candidate GEN-011
seekingalpha.com - September 22 at 10:18 AM
Genocea Announces FDA Acceptance of GEN-011 IND ApplicationGenocea Announces FDA Acceptance of GEN-011 IND Application
finance.yahoo.com - September 22 at 10:18 AM
Genocea Biosciences announces follow-up data from GEN-009 Neoantigen Vaccine phase 1/2a trialGenocea Biosciences announces follow-up data from GEN-009 Neoantigen Vaccine phase 1/2a trial
seekingalpha.com - September 17 at 7:37 AM
Genocea Biosciences announces follow-up data from GEN-009 Neoantigen VaccineGenocea Biosciences announces follow-up data from GEN-009 Neoantigen Vaccine
seekingalpha.com - September 17 at 7:37 AM
Genocea Presents Follow-up Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial at ESMO Virtual Congress 2020Genocea Presents Follow-up Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial at ESMO Virtual Congress 2020
finance.yahoo.com - September 17 at 7:37 AM
Are Options Traders Betting on a Big Move in Genocea Biosciences (GNCA) Stock?Are Options Traders Betting on a Big Move in Genocea Biosciences (GNCA) Stock?
finance.yahoo.com - September 15 at 12:24 PM
Genocea to Present at the ESMO Virtual Congress and Two Investor Conferences in SeptemberGenocea to Present at the ESMO Virtual Congress and Two Investor Conferences in September
finance.yahoo.com - September 3 at 10:13 PM
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Genocea Biosciences, Inc. for Potential Breach of FiduciaryINVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Genocea Biosciences, Inc. for Potential Breach of Fiduciary
bloomberg.com - September 1 at 9:53 AM
Genocea -1.8% as holders file to offer 21.39M sharesGenocea -1.8% as holders file to offer 21.39M shares
seekingalpha.com - August 18 at 11:29 PM
Genocea under pressure on underwhelming neoantigen vaccine dataGenocea under pressure on underwhelming neoantigen vaccine data
seekingalpha.com - July 30 at 2:29 PM
Genocea to Present Positive Preliminary Clinical Data Evaluating Neoantigen Vaccine GEN-009 in Combination with Checkpoint InhibitorsGenocea to Present Positive Preliminary Clinical Data Evaluating Neoantigen Vaccine GEN-009 in Combination with Checkpoint Inhibitors
finance.yahoo.com - July 30 at 9:28 AM
Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2020 Results - Earnings Call TranscriptGenocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - July 23 at 12:28 PM
Genocea Provides Second Quarter 2020 Corporate UpdateGenocea Provides Second Quarter 2020 Corporate Update
finance.yahoo.com - July 23 at 7:28 AM
Genocea secures equity capital of $80MGenocea secures equity capital of $80M
seekingalpha.com - July 22 at 10:41 AM
Genocea Announces Private Placement Financing of Up to $80 MillionGenocea Announces Private Placement Financing of Up to $80 Million
finance.yahoo.com - July 22 at 10:41 AM
Genocea Biosciences provides clinical update for GEN-009 and GEN-011Genocea Biosciences provides clinical update for GEN-009 and GEN-011
seekingalpha.com - July 20 at 3:03 PM
Genocea Biosciences Provides Clinical UpdateGenocea Biosciences Provides Clinical Update
finance.yahoo.com - July 20 at 10:02 AM
Genocea to Host Second Quarter 2020 Corporate Update Conference Call & WebcastGenocea to Host Second Quarter 2020 Corporate Update Conference Call & Webcast
finance.yahoo.com - July 16 at 9:59 AM
Genocea to Host Second Quarter 2020 Corporate Update Conference Call & WebcastGenocea to Host Second Quarter 2020 Corporate Update Conference Call & Webcast
finance.yahoo.com - July 16 at 9:59 AM
This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.